The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Mutations in proteasome subunit β type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity
Open accessAbstract
Objective: Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE syndrome) is an autoinflammatory syndrome recently described in children. We undertook this study to investigate the clinical phenotype, genetic cause, and immune dysregulation in 9 CANDLE syndrome patients. Methods: Genomic DNA from all patients was screened for mutations in PSMB8 (proteasome subunit β type 8). Cytokine levels were measured in sera from 3 patients. Skin biopsy samples were evaluated by immunohistochemistry, and blood microarray profile and STAT‐1 phosphorylation were assessed in 4 patients and 3 patients, respectively. Results: One patient was homozygous for a novel nonsense mutation in PSMB8 (c.405C>A), suggesting a protein truncation; 4 patients were homozygous and 2 were heterozygous for a previously reported missense mutation (c.224C>T); and 1 patient showed no mutation. None of these sequence changes was observed in chromosomes from 750 healthy controls. Of the 4 patients with the same mutation, only 2 shared the same haplotype, indicating a mutational hot spot. PSMB8 mutation–positive and –negative patients expressed high levels of interferon‐γ (IFNγ)–inducible protein 10. Levels of monocyte chemotactic protein 1, interleukin‐6 (IL‐6), and IL‐1 receptor antagonist were moderately elevated. Microarray profiles and monocyte STAT‐1 activation suggested a unique IFN signaling signature, unlike in other autoinflammatory disorders. Conclusion: CANDLE syndrome is caused by mutations in PSMB8, a gene recently reported to cause “JMP” syndrome (joint contractures, muscle atrophy, microcytic anemia, and panniculitis‐induced childhood‐onset lipodystrophy) in adults. We extend the clinical and pathogenic description of this novel autoinflammatory syndrome, thereby expanding the clinical and genetic disease spectrum of PSMB8‐associated disorders. IFN may be a key mediator of the inflammatory response and may present a therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reits, E. A., Hodge, J. W., Herberts, C. A., Groothuis, T. A., Chakraborty, M., K.Wansley, E., Camphausen, K., Luiten, R. M., de Ru, A. H., Neijssen, J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052494 · Cited by 1,737
Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease
Masters, S. L., Simon, A., Aksentijevich, I., & Kastner, D. L. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141627 · Cited by 1,065
A Proposed Classification of the Immunological Diseases
McGonagle, D., & McDermott, M. F. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030297 · Cited by 840
Immunoproteasomes Preserve Protein Homeostasis upon Interferon-Induced Oxidative Stress
Seifert, U., Bialy, L. P., Ebstein, F., Bech-Otschir, D., Voigt, A., Schröter, F., Prozorovski, T., Lange, N., Steffen, J., Rieger, M., et al. (2010) · Cell · doi:10.1016/j.cell.2010.07.036 · Cited by 551
The Structure of the Mammalian 20S Proteasome at 2.75 Å Resolution
Unno, M., Mizushima, T., Morimoto, Y., Tomisugi, Y., Tanaka, K., Yasuoka, N., & Tsukihara, T. (2002) · Structure · doi:10.1016/s0969-2126(02)00748-7 · Cited by 519
Jung, T., Catalgol, B., & Grune, T. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.04.001 · Cited by 389
HomozygosityMapper--an interactive approach to homozygosity mapping
Seelow, D., Schuelke, M., Hildebrandt, F., & Nurnberg, P. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp369 · Cited by 365
CXCL10 and autoimmune diseases
Lee, E. Y., Lee, Z.-H., & Song, Y. W. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.12.002 · Cited by 357
Agarwal, A. K., Xing, C., DeMartino, G. N., Mizrachi, D., Hernandez, M. D., Sousa, A. B., Martínez de Villarreal, L., dos Santos, H. G., & Garg, A. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.10.031 · Cited by 335
Torrelo, A., Patel, S., Colmenero, I., Gurbindo, D., Lendínez, F., Hernández, A., López-Robledillo, J. C., Dadban, A., Requena, L., & Paller, A. S. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.04.046 · Cited by 215
Self-citationMedicherla, B., & Goldberg, A. L. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200803022 · Cited by 175
Rivett, A. J., & Hearn, A. R. (2004) · Current Protein and Peptide Science · doi:10.2174/1389203043379774 · Cited by 127
Garg, A., Hernandez, M. D., Sousa, A. B., Subramanyam, L., Villarreal, L., dos Santos, H. G., & Barboza, O. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0488 · Cited by 98
Blocking Interleukin‐1 in Rheumatic Diseases
Goldbach‐Mansky, R. T. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05159.x · Cited by 97
Self-citationImmunoproteasomes are essential for survival and expansion of T cells in virus‐infected mice
Moebius, J., van den Broek, M. F., Groettrup, M., & Basler, M. (2010) · European Journal of Immunology · doi:10.1002/eji.201040620 · Cited by 91
Regulation of translation is required for dendritic cell function and survival during activation
Lelouard, H., Schmidt, E. K., Camosseto, V., Clavarino, G., Ceppi, M., Hsu, H.-T., & Pierre, P. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200707166 · Cited by 88
The seven dirty little secrets of major histocompatibility complex class I antigen processing
Yewdell, J. W. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00309.x · Cited by 75
Monogenic autoinflammatory diseases: new insights into clinical aspects and pathogenesis
Henderson, C., & Goldbach‐Mansky, R. T. (2010) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32833ceff4 · Cited by 69
Self-citationInterferon-gamma coordinates CCL3-mediated neutrophil recruitment in vivo
Bonville, C. A., Percopo, C. M., Dyer, K. D., Gao, J., Prussin, C., Foster, B. A., Rosenberg, H. F., & Domachowske, J. B. (2009) · BMC Immunology · doi:10.1186/1471-2172-10-14 · Cited by 61
Viricidal effect of stimulated human mononuclear phagocytes on human immunodeficiency virus type 1.
Chase, M., & Klebanoff, S. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5582 · Cited by 33
Cited by
Activated STING in a Vascular and Pulmonary Syndrome
Liu, Y., Jesus, A. A., Marrero, B., Yang, D., Ramsey, S. E., Montealegre Sanchez, G. A., Tenbrock, K., Wittkowski, H., Jones, O. Y., Kuehn, H. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312625 · Cited by 1,412
Self-citationIFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy
Ivashkiv, L. B. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0029-z · Cited by 1,358
Aicardi–Goutières syndrome and the type I interferonopathies
Crow, Y. J., & Manel, N. (2015) · Nature Reviews Immunology · doi:10.1038/nri3850 · Cited by 925
Practice parameter for the diagnosis and management of primary immunodeficiency
Bonilla, F. A., Khan, D. A., Ballas, Z. K., Chinen, J., Frank, M. M., Hsu, J. T., Keller, M., Kobrynski, L. J., Komarow, H. D., Mazer, B., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.04.049 · Cited by 791
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
Sanchez, G. A. M., Reinhardt, A., Ramsey, S., Wittkowski, H., Hashkes, P. J., Berkun, Y., Schalm, S., Murias, S., Dare, J. A., Brown, D., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98814 · Cited by 536
Self-citation
Metadata
- Authors
- Liu, Y., Ramot, Y., Torrelo, A., Paller, A. S., Si, N., Babay, S., Kim, P. W., Sheikh, A., Lee, C. R., Chen, Y., Vera, A., Zhang, X., Goldbach‐Mansky, R., & Zlotogorski, A.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2012-02-28
- Volume
- 64
- Issue
- 3
- Pages
- 895-907
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2066635545
- Cited by
- 406
- References
- 20
- FWCI
- 9.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.